BEYOND RESPIRATORY DAMAGE – NEUROLOGICAL INVOLVEMENT IN SARS-CoV-2 INFECTION

  • Iulia Elena DIACONU University of Medicine and Pharmacy ”Grigore T. Popa” Iași
  • Maria Ioana ONOFREI University of Medicine and Pharmacy ”Grigore T. Popa” Iași
  • Ioana Florina MIHAI University of Medicine and Pharmacy ”Grigore T. Popa” Iași
  • Georgiana Enache LEONTE University of Medicine and Pharmacy ”Grigore T. Popa” Iași
  • M. HURMUZACHE University of Medicine and Pharmacy ”Grigore T. Popa” Iași
  • Mihaela Catalina LUCA University of Medicine and Pharmacy ”Grigore T. Popa” Iași
Keywords: SARS-CoV-2 INFECTION, NEUROLOGICAL, HEADACHE, CONFUSION

Abstract

Although the respiratory damage associated with SARS-CoV-2 infection is well known, clinical and experimental studies have shown that the Coronaviridae family has a certain tropism for both the central and peripheral nervous system. Most patients with this pathology also associate neurological manifestations, often of a central type, with varying degrees of difficulty. The aim of this study was to evaluate the newly developed neurological manifestations in SARS-CoV-2 infected hospitalized patients. Material and method: We retrospectively analyzed medical records of patients with SARS-CoV-2 infection admitted in the Clinical Hospital of Infectious Diseases “Sf. Parascheva” Iasi between May 2020 – May 2022. Clinical features, frequency and correlation with risk factors (for example age, gender, comorbidities) and also severity of infection were evaluated. Results: We have identified 133 patients hospitalized during analyzed period and the majority presented significant comorbidities (94.84% cases). Fatigability (51.88% cases), myalgia (32.33% cases), impaired consciousness (decreased consciousness or confusion to encephalopathy) (27.88% cases), headache (28.57% cases) were the most frequent neurological features identified. A changing pattern in neurological manifestations was found during the pandemics’ waves, with an increase of incidence of fatigability and myalgia during the fifth wave of pandemic. Conclusions: Neurological symptoms were a relatively constant part of the clinical picture of SARS-CoV-2 infection. They had polymorphic and various features during the pandemic waves. The incidence of headache, myalgia and fatigability was highly increased during the last wave of pandemics. Impairment of consciousness was significantly correlated with age, neurological and cardiovascular comorbidities.

Author Biographies

Maria Ioana ONOFREI, University of Medicine and Pharmacy ”Grigore T. Popa” Iași

Clinical Hospital of Infectious Diseases “Sf. Parascheva” Iași

Ioana Florina MIHAI, University of Medicine and Pharmacy ”Grigore T. Popa” Iași

County Emergency Hospital, Bacau

Georgiana Enache LEONTE, University of Medicine and Pharmacy ”Grigore T. Popa” Iași

Clinical Hospital of Infectious Diseases “Sf. Parascheva” Iași

M. HURMUZACHE, University of Medicine and Pharmacy ”Grigore T. Popa” Iași

Clinical Hospital of Infectious Diseases “Sf. Parascheva” Iași

Mihaela Catalina LUCA, University of Medicine and Pharmacy ”Grigore T. Popa” Iași

Clinical Hospital of Infectious Diseases “Sf. Parascheva” Iași

References

1. https://www.worldometers.info/coronavirus/ (Accessed on 05 November 2022)
2. Lazzerini M., Sforzi I., Trapani S., et al. Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020. Euro Surveill 2021; 26(14): 2001248.
3. Miftode E, Luca C, Manciuc C, et al. COVID-19: a course through stormy waters. The Medical-Surgical Journal 2020; 124 (3): 351-362.
4. Pavel B, Moroti R, Spataru A, et al. Neurological Manifestations of SARS-CoV-2 Infection: A Narrative Review. Brain Sci 2022; 12(11): 1531.
5. Pinzon RT, Wijaya VO, Buana RB, et al. Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis. Front Neurol 2020; 11: 565.
6. Cucchiara B.L., Koralnik I.J. COVID-19: Neurologic complications and management of neurologic conditions. Available at https://www.uptodate.com/contents/covid-19-neurologic-complications-and-management-of-neurologic-conditions (Accessed on 05 November 2022).
7. Guadarrama-Ortiz P, Choreño-Parra JA, Sánchez-Martínez CM, et al. Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations. Front Neurol 2020; 11: 1039.
8. Mahboubi Mehrabani M, Karvandi MS, et al. Neurological complications associated with COVID-19; molecular mechanisms and therapeutic approaches. Rev Med Virol 2022; 32(6): e2334
9. Amin R, Sohrabi MR, Zali AR, et al. Five consecutive epidemiological waves of COVID-19: a population-based cross-sectional study on characteristics, policies, and health outcome. BMC Infect Dis 2022; 22: 906.
10. Iuliano AD, Brunkard JM, Boehmer TK, et al. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022. MMWR Morb Mortal Wkly Rep 2022; 71(4): 146-152.
11. Kim HK, Cho YJ, Lee SY. Neurological Manifestations in Patients with COVID-19: Experiences from the Central Infectious Diseases Hospital in South Korea. J Clin Neurol 2021; 17(3): 435-442.
12. Chu JY, Moe GW, Vyas MV, et al. Epidemiology of COVID-19 and its cardiac and neurologic complications among Chinese and South Asians in Ontario: waves 1, 2, and 3. CJC Open 2022; 4(10): 894-904.
13. Rogers JP, Watson CJ, Badenoch J, et al. Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives. J Neurol Neurosurg Psychiatry 2021; 92(9): 932-941.
14. Tsai ST, Lu MK, San S, et al. The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review. Front Neurol 2020; 11: 498.
15. Akoumianaki E, Vaporidi K, Bolaki M, Georgopoulos D. Happy or Silent Hypoxia in COVID-19-A Misnomer Born in the Pandemic Era. Front Physiol 2021; 12: 745634
16. Ssentongo P, Ssentongo AE, Voleti N, et al. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis. BMC Infect Dis 2022; 22: 439.
Published
2022-12-27
Section
INTERNAL MEDICINE - PEDIATRICS